Dr James Evans, a healthcare researcher at SMTL, has had a paper published in the Pacing and Clinical Electrophysiology (PACE) journal (Evans, J. M., Withers, K. L., Lencioni, M. , Carolan‐Rees, G. , Wood, K. A., Patrick, H. and Griffith, M. (2019), Quality of Life Benefits from Arrhythmia Ablation: A longitudinal study using the C‐CAP questionnaire and EQ5D. Pacing Clin Electrophysiol. Accepted Author Manuscript. doi:10.1111/pace.13675).
James carried out the work whilst working at Cedar. The study presents results for generic and arrhythmia related quality of life using patient reported outcomes gathered at baseline, post-ablation and at 1 year follow-up.
Results showed significant improvements in symptom severity, impact on life scores, EQ-5D-5L indices and VAS scores at baseline versus three months (post-ablation) and at baseline versus 1 year follow-up. Impact on life score showed additional improvement at 1 year follow-up versus three months, while improvements in symptom severity, EQ-5D-5L indices and VAS scores continued to be maintained between 3 months and 1 year follow-up.
Cardiac ablation therefore provides patients with arrhythmias relief from symptoms, and results in an improvement in quality of life.